- Home
- ALTO vs LXRX Comparison
ALTO vs LXRX Comparison
Compare ALTO & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- LXRX
- Stock Information
- Founded
- ALTO 2003
- LXRX 1995
- Country
- ALTO United States
- LXRX United States
- Employees
- ALTO N/A
- LXRX N/A
- Industry
- ALTO Major Chemicals
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTO Industrials
- LXRX Health Care
- Exchange
- ALTO Nasdaq
- LXRX Nasdaq
- Market Cap
- ALTO 123.0M
- LXRX 124.4M
- IPO Year
- ALTO N/A
- LXRX 2000
- Fundamental
- Price
- ALTO $1.17
- LXRX $0.57
- Analyst Decision
- ALTO Strong Buy
- LXRX Buy
- Analyst Count
- ALTO 1
- LXRX 4
- Target Price
- ALTO $5.50
- LXRX $3.67
- AVG Volume (30 Days)
- ALTO 704.0K
- LXRX 29.6M
- Earning Date
- ALTO 03-05-2025
- LXRX 03-06-2025
- Dividend Yield
- ALTO N/A
- LXRX N/A
- EPS Growth
- ALTO N/A
- LXRX N/A
- EPS
- ALTO N/A
- LXRX N/A
- Revenue
- ALTO $965,258,000.00
- LXRX $31,081,000.00
- Revenue This Year
- ALTO $7.95
- LXRX N/A
- Revenue Next Year
- ALTO N/A
- LXRX $101.91
- P/E Ratio
- ALTO N/A
- LXRX N/A
- Revenue Growth
- ALTO N/A
- LXRX 2481.48
- 52 Week Low
- ALTO $1.15
- LXRX $0.28
- 52 Week High
- ALTO $2.40
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- ALTO 34.55
- LXRX 59.98
- Support Level
- ALTO $1.20
- LXRX $0.32
- Resistance Level
- ALTO $1.40
- LXRX $0.41
- Average True Range (ATR)
- ALTO 0.09
- LXRX 0.04
- MACD
- ALTO -0.01
- LXRX 0.03
- Stochastic Oscillator
- ALTO 6.67
- LXRX 65.92
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.